Cesca CLI Feasibility Study Published in Peer-Reviewed Journal
RANCHO CORDOVA, Calif., March 20, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced the publication in a peer reviewed journal of …